Verquvo

$160.00$290.00

Verquvo (generic name: vericiguat) is an oral medication prescribed for adults with chronic heart failure symptoms classified as HFrEF (ejection fraction less than 45%.) Vericiguat is a novel drug that acts as a soluble guanylate cyclase (sGC) stimulator. It increases cyclic guanosine monophosphate (cGMP) levels, leading to vasodilation and improved cardiac function. It is used primarily to reduce the risk of severe cardiovascular events leading to hospitalization for heart failure. Heart failure is when the heart is weak and cannot pump enough blood to the body. Patients with HFrEF can exhibit symptoms like shortness of breath, fatigue, reduced capacity to exercise, fluid retention (edema), and accelerated heartbeat.

SKU: N/A Category: